Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10BRISTOL

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
ELCC
Not Confirmed
arrow
ELCC
Not Confirmed

REPOTRECTINIB

US Patent Number : 11452725

Drug Substance Claim :

Drug Product Claim :

Application Number : 218213

Patent Use Code : U-3755

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-24

blank

02

arrow
ELCC
Not Confirmed
arrow
ELCC
Not Confirmed

REPOTRECTINIB

US Patent Number : 11452725

Drug Substance Claim :

Drug Product Claim :

Application Number : 218213

Patent Use Code : U-3961

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-24

blank

03

arrow
ELCC
Not Confirmed
arrow
ELCC
Not Confirmed

REPOTRECTINIB

US Patent Number : 11452725

Drug Substance Claim :

Drug Product Claim :

Application Number : 218213

Patent Use Code : U-3961

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-24

blank

04

arrow
ELCC
Not Confirmed
arrow
ELCC
Not Confirmed

REPOTRECTINIB

US Patent Number : 11452725

Drug Substance Claim :

Drug Product Claim :

Application Number : 218213

Patent Use Code : U-3755

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-24

blank

05

arrow
ELCC
Not Confirmed
arrow
ELCC
Not Confirmed

REPOTRECTINIB

US Patent Number : 10294242

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 218213

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-05

blank

06

arrow
ELCC
Not Confirmed
arrow
ELCC
Not Confirmed

REPOTRECTINIB

US Patent Number : 10294242

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 218213

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-05

blank

07

arrow
ELCC
Not Confirmed
arrow
ELCC
Not Confirmed

REPOTRECTINIB

US Patent Number : 12187739

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 218213

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-05

blank

08

arrow
ELCC
Not Confirmed
arrow
ELCC
Not Confirmed

REPOTRECTINIB

US Patent Number : 9714258

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 218213

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-01-23

blank

09

arrow
ELCC
Not Confirmed
arrow
ELCC
Not Confirmed

REPOTRECTINIB

US Patent Number : 12187739

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 218213

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-05

blank

10

arrow
ELCC
Not Confirmed
arrow
ELCC
Not Confirmed

REPOTRECTINIB

US Patent Number : 9714258

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 218213

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-01-23

blank